Colleran David
SEC CIK 1646558 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | EVP, GC, Corp Sec | 62.5K | $72.0K | — | 25 | 2022-03-04 | 2026-03-14 |
Most active insiders at ANIK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Griffin Stephen D. | Pres, CEO, Dir | $149.9K | — |
| 2 | HENNEMAN JOHN B III | Dir | $73.3K | — |
| 3 | Fischetti Gary P | Dir | $41.1K | — |
| 4 | Richard Stephen | Dir | — | — |
| 5 | Colleran David | EVP, GC, Corp Sec | — | — |
| 6 | Capper Joseph H | Dir | — | — |
| 7 | McLeod Ian | SVP, CAO, Treas | — | — |
| 8 | Blanchard Cheryl R | Dir | — | — |
| 9 | CONLEY SHERYL L | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | — | +15.8K | 62.5K | +34% | — |
| DM | 2026-03-17 | 2026-03-14+ | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $14.20 | -6,061 | 67.6K | -8% | -$86.1K |
| D | 2026-03-17 | 2026-03-14 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | A - Grant | $0.00 | +4,694 | 67.2K | +8% | $0 |
| D | 2026-03-11 | 2026-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | — | +5,465 | 55.0K | +11% | — |
| D | 2026-03-11 | 2026-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $14.96 | -1,919 | 53.1K | -3% | -$28.7K |
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +6,448 | 49.8K | +15% | $0 |
| D | 2025-03-18 | 2025-03-17 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $15.91 | -1,893 | 48.0K | -4% | -$30.1K |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $16.79 | -2,250 | 43.4K | -5% | -$37.8K |
| D | 2025-03-13 | 2025-03-11 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +7,663 | 45.6K | +20% | $0 |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $16.62 | -1,604 | 38.0K | -4% | -$26.7K |
| D | 2025-03-11 | 2025-03-10 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +5,465 | 39.6K | +16% | $0 |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +16.8K | 35.2K | +91% | $0 |
| DM | 2024-03-12 | 2024-03-11 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $25.59 | -4,936 | 33.0K | -13% | -$126.3K |
| D | 2023-03-14 | 2023-03-10 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $26.10 | -2,250 | 20.3K | -10% | -$58.7K |
| D | 2023-03-14 | 2023-03-10 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +7,663 | 22.5K | +52% | $0 |
| D | 2023-03-10 | 2023-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $26.91 | -1,081 | 14.9K | -7% | -$29.1K |
| D | 2023-03-10 | 2023-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +3,683 | 16.0K | +30% | $0 |
| D | 2023-03-07 | 2023-03-04 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +2,500 | 13.0K | +24% | $0 |
| D | 2023-03-07 | 2023-03-04 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $31.59 | -734 | 12.3K | -6% | -$23.2K |
| 2022-05-12 | 2022-05-11 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | P - Purchase | $21.37 | +1,500 | 9,867 | +18% | +$32.1K | |
| 2022-03-16 | 2022-03-14 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | P - Purchase | $26.65 | +1,500 | 8,367 | +22% | +$40.0K | |
| D | 2022-03-11 | 2022-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $26.22 | -1,081 | 6,867 | -14% | -$28.3K |
| D | 2022-03-11 | 2022-03-09 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +3,682 | 7,948 | +86% | $0 |
| D | 2022-03-07 | 2022-03-04 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | M - OptEx | $0.00 | +2,500 | 5,000 | +100% | $0 |
| D | 2022-03-07 | 2022-03-04 | ANIK | Anika Therapeutics, Inc. | Colleran David | EVP, GC, Corp Sec | F - Tax | $31.06 | -734 | 4,266 | -15% | -$22.8K |
Purchase Sale Sale after option exercise All abbreviations